Marker Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Marker Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2014 to Q3 2024.
  • Marker Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 8.92M shares, a 1.1% increase year-over-year.
  • Marker Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 8.81M shares, a 5.49% increase from 2022.
  • Marker Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 8.35M shares, a 9.16% increase from 2021.
  • Marker Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 7.65M shares, a 83.7% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 8.92M +97.3K +1.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 8.92M +119K +1.36% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 8.9M +181K +2.08% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 8.81M +458K +5.49% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 8.83M +466K +5.57% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 8.8M +440K +5.26% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 8.72M +410K +4.94% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 8.35M +700K +9.16% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 8.36M -74.7M -89.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 8.36M -74.7M -89.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 8.31M -48.2M -85.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 7.65M -39.4M -83.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 83.1M +36.2M +77.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 83M +36.5M +78.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 56.5M +10.4M +22.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 47M +1.45M +3.19% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 46.9M +1.21M +2.65% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 46.6M +1.07M +2.36% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 46.1M +619K +1.36% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 45.6M +26.5M +139% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 45.7M +31.9M +232% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 45.5M +33.7M +284% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 45.5M +34.8M +328% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 19.1M +9.64M +102% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 13.7M +3.51M +34.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 11.8M +3.26M +38% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 10.6M +2.19M +26% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 9.45M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 10.2M +2.94M +40.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 8.58M +2.64M +44.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 8.43M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q3 2016 7.28M +3.23M +79.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 5.94M -27.6M -82.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q3 2015 4.05M -13.3M -76.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 33.5M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q3 2014 17.3M Jul 1, 2014 Sep 30, 2014 10-Q/A 2016-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.